Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation
Clinical trial NCT05450328 · RECRUITING
Trial details
- NCT number
- NCT05450328
- Sponsor
- Montreal Heart Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2028-05-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.